A year of careful medical-communications work once died unused in the field. Kinetix Health Group is betting that pharma does not need another deck - it needs a system that keeps evidence moving.
The West Chester agency built two businesses around one stubborn problem: good science is useless if nobody can understand, approve, or act on it.
HDMZ spent decades learning how to explain difficult science. Its more interesting trick is deciding what should be explained at all - by starting at the desired business outcome and plotting backward.
Samba Scientific hires people who can read the paper, question the claim and still build the campaign. The wager is simple: in biotech, fluency is not decoration - it is the shortest route from a complicated product to a credible lead.
BRG found a profitable corner of public relations where the facts are dense, the stakes are human, and attention is never guaranteed. Its trick is not louder publicity - it is translating evidence into something people can use.
Medical teams at drug companies read maybe 10% of the evidence that matters. Sorcero built AI agents to read the other 90% - and about a third of the top 30 global pharma companies are now paying for it.